A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
April 17, 2018
Primary Completion Date
June 26, 2018
Study Completion Date
June 26, 2018
Conditions
Healthy Male Participants
Interventions
DRUG
[14C]-E6007
Oral administration
Trial Locations (1)
Unknown
Covance Clinical Research Unit (CRU) Ltd., Leeds
All Listed Sponsors
lead
EA Pharma Co., Ltd.
INDUSTRY
NCT03444818 - A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants | Biotech Hunter | Biotech Hunter